Theriva Biologics, Inc. Cash and Cash Equivalents
Theriva Biologics, Inc. (TOVX) had Cash and Cash Equivalents of $11.34 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-11
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $11.34M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $14.43M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $13.06M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $7.53M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $11.34M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $14.43M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $13.06M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $7.53M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $12.12M 10-Q · filed 2026-08-11 | |
| 2025-03-31 | $10.01M 10-Q · filed 2026-05-05 | |
| 2024-12-31 | $11.61M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $16.41M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $16.59M 10-Q · filed 2025-08-11 | |
| 2024-03-31 | $18.26M 10-Q · filed 2025-05-14 | |
| 2023-12-31 | $23.18M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $31.16M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $34.25M 10-Q · filed 2024-08-13 | |
| 2023-03-31 | $36.08M 10-Q · filed 2024-05-07 | |
| 2022-12-31 | $41.79M 10-K · filed 2024-03-25 | |
| 2022-09-30 | $50.49M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $52.27M 10-Q · filed 2023-08-08 | |
| 2022-03-31 | $56.69M 10-Q · filed 2023-05-11 | |
| 2021-12-31 | $67.33M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $72.14M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $74.29M 10-Q · filed 2022-08-11 | |
| 2021-03-31 | $76.89M 10-Q · filed 2022-05-16 | |
| 2020-12-31 | $6.23M 10-K · filed 2022-03-16 | |
| 2020-09-30 | $6.00M 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $8.06M 10-Q · filed 2021-08-05 | |
| 2020-03-31 | $10.09M 10-Q · filed 2021-05-05 | |
| 2019-12-31 | $15.04M 10-Q · filed 2021-11-03 | |
| 2019-09-30 | $18.65M 10-Q · filed 2020-11-10 | |
| 2019-08-31 | $20.10M 10-Q · filed 2019-08-08 | |
| 2019-06-30 | $21.71M 10-Q · filed 2020-08-06 | |
| 2019-05-31 | $23.00M 10-Q · filed 2019-05-08 | |
| 2019-03-31 | $24.69M 10-Q · filed 2020-05-05 | |
| 2019-02-28 | $26.00M 10-K · filed 2019-02-27 | |
| 2018-12-31 | $28.92M 10-K · filed 2021-03-04 | |
| 2018-09-30 | $9.55M 10-Q · filed 2019-11-04 | |
| 2018-06-30 | $7.13M 10-Q · filed 2019-08-08 | |
| 2018-03-31 | $11.04M 10-Q · filed 2019-05-08 | |
| 2017-12-31 | $17.12M 10-K · filed 2020-02-20 | |
| 2017-09-30 | $21.05M 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $13.38M 10-Q · filed 2018-08-08 | |
| 2017-03-31 | $13.47M 10-Q · filed 2018-05-08 | |
| 2016-12-31 | $19.05M 10-K · filed 2019-02-27 | |
| 2016-09-30 | $4.55M 10-Q · filed 2017-11-01 | |
| 2016-06-30 | $10.05M 10-Q · filed 2017-08-03 | |
| 2016-03-31 | $15.10M 10-Q · filed 2017-05-04 | |
| 2015-12-31 | $20.82M 10-K · filed 2018-02-22 | |
| 2015-09-30 | $31.81M 10-Q · filed 2016-11-01 | |
| 2015-06-30 | $4.76M 10-Q · filed 2016-08-03 | |
| 2015-03-31 | $12.05M 10-Q · filed 2016-05-05 | |
| 2014-12-31 | $17.52M 10-K · filed 2018-02-22 | |
| 2014-09-30 | $3.29M 10-Q · filed 2015-11-05 | |
| 2014-06-30 | $7.84M 10-Q · filed 2015-08-10 | |
| 2014-03-31 | $11.15M 10-Q · filed 2015-05-11 | |
| 2013-12-31 | $14.63M 10-K · filed 2017-03-02 | |
| 2013-09-30 | $5.14M 10-Q · filed 2014-11-14 | $5.10M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $6.88M 10-Q · filed 2014-08-14 | $6.90M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $8.52M 10-Q · filed 2014-05-15 | $7.60M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $9.95M 10-K · filed 2016-03-10 | $9.60M 10-Q · filed 2013-05-15 |
| 2012-09-30 | $4.50M 10-Q · filed 2012-11-14 | |
| 2011-12-31 | $6.68M 10-K · filed 2015-03-16 | $5.00M 10-Q · filed 2012-11-14 |
| 2011-09-30 | $4.61M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $8.39M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $2.65M 10-Q · filed 2011-11-14 | |
| 2010-09-30 | $3.31M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $3.27M 10-Q · filed 2011-08-15 | |
| 2009-12-31 | $2.72M 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |